Incyte (INCY) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Incyte Corporation  (NASDAQ: INCY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Incyte's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INCY Gross Profit Margin (Sep 30 2026)
Q3 		(Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3
Y / Y Revenue Change 14 %
Seq. Revenue Change -6.98 %
Revenue In Millions $1,557.20
Gross Profit Margin 93.02 %
Gross Profit Margin Total Ranking # 321
Gross Profit In Millions $1,448.46
Y / Y Gross Profit Change 14.32 %
Seq. Gross Profit Change -


Commenting Third Quarter 2026 Gross Profit Margin
Incyte Corporation achieved Gross Profit of $1,448 millions compare to Gross Loss of $0.00 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -6.98 % Incyte Corporation managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 1,448 compare to Gross Loss of $0.00 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 93.02 %, below company average.


Observing third quarter 2026 results within Medical Laboratories industry 3 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 321, from total ranking in the previous quarter at 354.
Learn about Gross Margin
INCY's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 4
Healthcare Sector # 50
Overall # 319

Gross Profit Margin Statistics
High Average Low
99.98 % 95.35 % 91.79 %
(Jun 30 2012)   (Mar 31 2026)


INCY Gross Income Trends • More of INCY's Profitabilty Ratios • INCY Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
INCY's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
INCY's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for INCY's Competitors
Gross Profit Margin Profit Margin for Incyte's Suppliers
Gross Profit Margin Profit Margin for INCY's Customers

You may also want to know
INCY's Annual Growth Rates INCY's Profitability Ratios INCY's Asset Turnover Ratio INCY's Dividend Growth
INCY's Roe INCY's Valuation Ratios INCY's Financial Strength Ratios INCY's Gross Profit Growth
INCY's Roa INCY's Inventory Turnover Ratio INCY's Growth Rates INCY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Laboratories Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Veracyte Inc   97.85 %$ 148.489  Millions$ 151.754  Millions
Miragen Therapeutics Inc   94.07 %$ 24.225  Millions$ 25.752  Millions
Incyte Corporation  93.02 %$ 1,448.460  Millions$ 1,557.204  Millions
Omniab Inc   84.52 %$ 3.375  Millions$ 3.993  Millions
Maxcyte inc   83.41 %$ 8.468  Millions$ 10.152  Millions
Castle Biosciences Inc   76.75 %$ 78.972  Millions$ 102.891  Millions
Butterfly Network Inc   73.02 %$ 23.802  Millions$ 32.598  Millions
Billiontoone Inc   70.86 %$ 87.145  Millions$ 122.981  Millions
Guardant Health Inc   65.42 %$ 236.153  Millions$ 360.975  Millions
Nrc Health  59.95 %$ 23.021  Millions$ 38.399  Millions
Exagen Inc   58.84 %$ 10.836  Millions$ 18.417  Millions
Caredx Inc   44.61 %$ 62.174  Millions$ 139.362  Millions
Aclarion Inc   43.86 %$ 0.015  Millions$ 0.034  Millions
Ge Healthcare Technologies Inc   40.34 %$ 2,224.000  Millions$ 5,513.000  Millions
Fulgent Genetics Inc   35.33 %$ 31.947  Millions$ 90.412  Millions
Iqvia Holdings Inc   33.83 %$ 1,498.000  Millions$ 4,428.000  Millions
Quest Diagnostics Inc  33.65 %$ 1,042.000  Millions$ 3,097.000  Millions
Medpace Holdings Inc   31.27 %$ 223.885  Millions$ 716.000  Millions
Labcorp Holdings Inc   29.08 %$ 1,108.100  Millions$ 3,810.000  Millions
Personalis Inc   25.67 %$ 6.570  Millions$ 25.596  Millions
Fortrea Holdings Inc   20.17 %$ 139.500  Millions$ 691.500  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.